Intellia Therapeutics News

Intellia Therapeutics | 424B5: Prospectus

Feb 26 07:05 ET

Intellia Therapeutics | 424B5: Prospectus

Feb 23 22:28 ET

Intellia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 8 00:00 ET

Intellia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 7, 2023 20:09 ET

Intellia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 31, 2023 16:45 ET

Intellia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 6, 2023 16:22 ET

Intellia Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Jun 20, 2023 19:39 ET

Intellia Therapeutics | 424B5: Prospectus

Dec 1, 2022 17:09 ET

Intellia Therapeutics | 424B5: Prospectus

Mar 4, 2022 17:03 ET

Intellia Therapeutics | 424B5: Prospectus

Jul 1, 2021 16:55 ET

Intellia Therapeutics | 424B5: Prospectus

Jun 28, 2021 16:02 ET

Intellia Therapeutics | 424B5: Prospectus

Dec 2, 2020 16:00 ET

Intellia Therapeutics | 424B5: Prospectus

Nov 30, 2020 17:06 ET

Intellia Therapeutics | 424B5: Prospectus

Jun 3, 2020 17:14 ET

Intellia Therapeutics | 424B5: Prospectus

Jun 1, 2020 16:52 ET

Intellia Therapeutics | EFFECT: Others

Sep 13, 2019 00:15 ET

Intellia Therapeutics | EFFECT: Others

Jun 7, 2019 00:15 ET

Intellia Therapeutics | 424B5: Prospectus

Nov 2, 2017 18:12 ET

Intellia Therapeutics | 424B5: Prospectus

Nov 1, 2017 07:11 ET

Intellia Therapeutics | EFFECT: Others

Jun 19, 2017 00:15 ET